These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7879129)

  • 1. Induction of mixed bone marrow chimerism as potential therapy for autoimmune (type I) diabetes: experience in the NOD model.
    Mathieu C; Bouillon R; Rutgeerts O; Waer M
    Transplant Proc; 1995 Feb; 27(1):640-1. PubMed ID: 7879129
    [No Abstract]   [Full Text] [Related]  

  • 2. Protection against autoimmune diabetes by induction of mixed bone marrow chimerism.
    Mathieu C; Vandeputte M; Bouillon R; Waer M
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1266-7. PubMed ID: 8442108
    [No Abstract]   [Full Text] [Related]  

  • 3. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice.
    Li H; Kaufman CL; Boggs SS; Johnson PC; Patrene KD; Ildstad ST
    J Immunol; 1996 Jan; 156(1):380-8. PubMed ID: 8598488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against autoimmune diabetes in mixed bone marrow chimeras: mechanisms involved.
    Mathieu C; Casteels K; Bouillon R; Waer M
    J Immunol; 1997 Feb; 158(3):1453-7. PubMed ID: 9013991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of diabetes in nonobese diabetic mice by nonmyeloablative allogeneic bone marrow transplantation.
    Elkin G; Prigozhina TB; Slavin S
    Exp Hematol; 2004 Jun; 32(6):579-84. PubMed ID: 15183899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of hemopoietic reconstitution in nonobese diabetic mice: dichotomy of allogeneic resistance versus competitive advantage of disease-resistant marrow.
    Kaufman CL; Li H; Ildstad ST
    J Immunol; 1997 Mar; 158(5):2435-42. PubMed ID: 9036994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice.
    Chan J; Clements W; Field J; Nasa Z; Lock P; Yap F; Toh BH; Alderuccio F
    J Gene Med; 2006 Nov; 8(11):1281-90. PubMed ID: 16989008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to the induction of mixed chimerism in spontaneously diabetic NOD mice depends on the CD40/CD154 pathway and donor MHC disparity.
    Luo B; Wu T; Pan Y; Sozen H; Hao J; Zhang Y; Sutherland DE; Hering BJ; Guo Z
    Ann N Y Acad Sci; 2007 Apr; 1103():94-102. PubMed ID: 17376827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low levels of allogeneic but not syngeneic hematopoietic chimerism reverse autoimmune insulitis in prediabetic NOD mice.
    Kaminitz A; Mizrahi K; Yaniv I; Farkas DL; Stein J; Askenasy N
    J Autoimmun; 2009 Sep; 33(2):83-91. PubMed ID: 19632089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow transplantation prevents autoimmune diabetes in nonobese diabetic mice.
    Georgiou HM; Slattery RM; Charlton B
    Transplant Proc; 1993 Oct; 25(5):2896-7. PubMed ID: 8212278
    [No Abstract]   [Full Text] [Related]  

  • 11. Distinct characteristics and features of allogeneic chimerism in the NOD mouse model of autoimmune diabetes.
    Zorina TD; Subbotin VM; Bertera S; Alexander AM; Haluszczak C; Styche AJ; Trucco M
    Cell Transplant; 2002; 11(2):113-23. PubMed ID: 12099635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of recipient lymphocytes in NOD mice after irradiation and bone marrow transplantation.
    Steptoe RJ; Stankovic S; Lopaticki S; Jones LK; Harrison LC; Morahan G
    J Autoimmun; 2004 Mar; 22(2):131-8. PubMed ID: 14987741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed bone marrow chimerism as a treatment for autoimmune diabetes.
    Leykin I; Nikolic B; Sykes M
    Transplant Proc; 2001; 33(1-2):120. PubMed ID: 11266737
    [No Abstract]   [Full Text] [Related]  

  • 14. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
    Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
    J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syngeneic islets transplanted into the thymus of newborn mice prevent diabetes and reduce insulitis in the NOD mouse.
    Nomura Y; Mullen Y; Stein E
    Transplant Proc; 1993 Feb; 25(1 Pt 2):963-4. PubMed ID: 8442281
    [No Abstract]   [Full Text] [Related]  

  • 16. Hematopoietic mixed chimerism derived from allogeneic embryonic stem cells prevents autoimmune diabetes mellitus in NOD mice.
    Verda L; Kim DA; Ikehara S; Statkute L; Bronesky D; Petrenko Y; Oyama Y; He X; Link C; Vahanian NN; Burt RK
    Stem Cells; 2008 Feb; 26(2):381-6. PubMed ID: 17975228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polygenic control of autoimmune diabetes in nonobese diabetic mice.
    Ghosh S; Palmer SM; Rodrigues NR; Cordell HJ; Hearne CM; Cornall RJ; Prins JB; McShane P; Lathrop GM; Peterson LB
    Nat Genet; 1993 Aug; 4(4):404-9. PubMed ID: 8401590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Regulatory phenomena in tolerance induction].
    Salaün J
    J Soc Biol; 2002; 196(4):259-61. PubMed ID: 12645291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E expression is needed on both bone marrow derived cells and thymic epithelium to increase IL-4 production and achieve protection in NOD bone marrow chimeras.
    Brenden N; Rietz C; Böhme J
    Cytokine; 1999 Oct; 11(10):766-72. PubMed ID: 10525315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced incidence of diabetes in nonobese diabetic mice transplanted with thymus from diabetes-resistant donors.
    Georgiou HM; Mandel TE
    Transplant Proc; 1992 Feb; 24(1):203-4. PubMed ID: 1539248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.